Search research articles
Contact Us
Filters
Showing results (221-230 of 274) with videos related to
Page
of 28
Sort By:
Cell Death and Differentiation
|
March 18, 2017
The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
Dana Almohazey, Yuan-Hung Lo, Claire V Vossler, et al.
Lancet (London, England)
|
November 24, 2025
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
Ghaith Noaiseh, Kathy L Sivils, Kim Campbell, et al.
Cells
|
August 12, 2022
High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer
Lui Ng, Timothy Ming-Hun Wan, Deepak Narayanan Iyer, et al.
International Journal of Molecular Sciences
|
June 18, 2020
Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer
Sai-Fung Chung, Chi-Fai Kim, Sui-Yi Kwok, et al.
The Journal of Rheumatology
|
December 2, 2021
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
Ronald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Gastroenterology
|
July 29, 2018
Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates
Adam D Gracz, Leigh Ann Samsa, Matthew J Fordham, et al.
Cancer Cell International
|
April 21, 2009
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
Sam-Mui Tsui, Wai-Man Lam, Tin-Lun Lam, et al.
Journal of Comparative Effectiveness Research
|
February 17, 2023
Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
Nanhua Zhang, Chunyan Liu, Steven J Steiner, et al.
Inflammatory Bowel Diseases
|
September 1, 2022
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity
Jeremy Adler, Richard B Colletti, Lenore Noonan, et al.
Stem Cell Reports
|
January 13, 2015
Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration
Shila Gilbert, Harini Nivarthi, Christopher N Mayhew, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 274) with videos related to
Sort By:
Page
of 28
Cell Death and Differentiation
|
March 18, 2017
The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
Dana Almohazey, Yuan-Hung Lo, Claire V Vossler, et al.
Lancet (London, England)
|
November 24, 2025
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
Ghaith Noaiseh, Kathy L Sivils, Kim Campbell, et al.
Cells
|
August 12, 2022
High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer
Lui Ng, Timothy Ming-Hun Wan, Deepak Narayanan Iyer, et al.
International Journal of Molecular Sciences
|
June 18, 2020
Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer
Sai-Fung Chung, Chi-Fai Kim, Sui-Yi Kwok, et al.
The Journal of Rheumatology
|
December 2, 2021
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
Ronald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Gastroenterology
|
July 29, 2018
Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates
Adam D Gracz, Leigh Ann Samsa, Matthew J Fordham, et al.
Cancer Cell International
|
April 21, 2009
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
Sam-Mui Tsui, Wai-Man Lam, Tin-Lun Lam, et al.
Journal of Comparative Effectiveness Research
|
February 17, 2023
Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
Nanhua Zhang, Chunyan Liu, Steven J Steiner, et al.
Inflammatory Bowel Diseases
|
September 1, 2022
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity
Jeremy Adler, Richard B Colletti, Lenore Noonan, et al.
Stem Cell Reports
|
January 13, 2015
Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration
Shila Gilbert, Harini Nivarthi, Christopher N Mayhew, et al.
Page
of 28